• Je něco špatně v tomto záznamu ?

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study

J. Burisch, P. Weimers, N. Pedersen, S. Cukovic-Cavka, B. Vucelic, I. Kaimakliotis, D. Duricova, M. Bortlik, O. Shonová, I. Vind, S. Avnstrøm, N. Thorsgaard, S. Krabbe, V. Andersen, JF. Dahlerup, J. Kjeldsen, R. Salupere, J. Olsen, KR. Nielsen,...

. 2014 ; 8 (9) : 1030-42.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023567

BACKGROUND & AIMS: Health-related quality of life (HRQoL) is impaired in patients with Inflammatory Bowel Disease (IBD). The aim was prospectively to assess and validate the pattern of HRQoL in an unselected, population-based inception cohort of IBD patients from Eastern and Western Europe. METHODS: The EpiCom inception cohort consists of 1560 IBD patients from 31 European centres covering a background population of approximately 10.1 million. Patients answered the disease specific Short Inflammatory Bowel Disease Questionnaire (SIBDQ) and generic Short Form 12 (SF-12) questionnaire at diagnosis and after one year of follow-up. RESULTS: In total, 1079 patients were included in this study. Crohn's disease (CD) patients mean SIBDQ scores improved from 45.3 to 55.3 in Eastern Europe and from 44.9 to 53.6 in Western Europe. SIBDQ scores for ulcerative colitis (UC) patients improved from 44.9 to 57.4 and from 48.8 to 55.7, respectively. UC patients needing surgery or biologicals had lower SIBDQ scores before and after compared to the rest, while biological therapy improved SIBDQ scores in CD. CD and UC patients in both regions improved all SF-12 scores. Only Eastern European UC patients achieved SF-12 summary scores equal to or above the normal population. CONCLUSION: Medical and surgical treatment improved HRQoL during the first year of disease. The majority of IBD patients in both Eastern and Western Europe reported a positive perception of disease-specific but not generic HRQoL. Biological therapy improved HRQoL in CD patients, while UC patients in need of surgery or biological therapy experienced lower perceptions of HRQoL than the rest.

1st Department of Medicine Semmelweis University Budapest Hungary

1st Division of Internal Medicine and Division of Gastroenterology Medical School University of Ioannina Ioannina Greece

Clinic of Gastroenterology University of Medicine 'Victor Babes' Timisoara Romania

Department of Gastroenterology Adelaide and Meath Hospital TCD Dublin Ireland

Department of Gastroenterology and Alimentary Tract Surgery Tampere University Hospital Tampere Finland

Department of Gastroenterology and Hepatology Ben Gurion University of the Negev Beer Sheva Israel

Department of Gastroenterology and Hepatology Soroka Medical Center and Ben Gurion University of the Negev Beer Sheva Israel

Department of Gastroenterology Hospital São João Porto Portugal

Department of Gastroenterology Moscow Regional Research Clinical Institute Moscow Russian Federation

Department of Gastroenterology State University of Medicine and Pharmacy of the Republic of Moldova Chisinau Republic of Moldova

Department of Gastroenterology UHL County Council of Östergötland Linköping Sweden

Department of Internal Medicine Section of Gastroenterology and Hepatology The National University Hospital Reykjavik Iceland

Department of Medical Gastroenterology Gentofte Hospital Copenhagen Denmark

Department of Medical Gastroenterology Odense University Hospital Odense Denmark

Department of Medicine 5 Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark

Department of Medicine Amager Hospital Amager Denmark

Department of Medicine Csolnoky F Province Hospital Veszprem Hungary

Department of Medicine Division of Gastroenterology Örebro University Hospital Örebro Sweden

Department of Medicine Herning Central Hospital Herning Denmark

Digestive Disease Centre Medical Section Herlev University Hospital Copenhagen Denmark

Division of Endocrinology and Gastroenterology Tartu University Hospital Tartu Estonia

Division of Gastroenterology and Hepatology Department of Medicine Karolinska Institutet Stockholm Sweden

Division of Gastroenterology and Hepatology University Hospital Center Zagreb University of Zagreb School of Medicine Zagreb Croatia

Gastroenterology Department Complexo Hospitalario Universitario de Vigo Vigo Spain

Gastroenterology Department Hospital České Budějovice České Budějovice Czech Republic

Gastroenterology Department POVISA Hospital Vigo Spain

Hospital de Vale de Sousa Porto Portugal

Hull and East Yorkshire NHS Trust and Hull and York Medical School Hull Royal Infirmary Hull UK

Hull and York Medical School Hull Royal Infirmary Hull UK

IBD Center ISCARE Charles University Prague Czech Republic

IBMC Institute for Molecular and Cell Biology University of Porto Porto Portugal

Institute for Digestive Research Lithuanian University of Health Sciences Kaunas Lithuania

Institute of Pharmacology and Therapeutics Faculty of Medicine University of Porto Porto Portugal

Institute of Regional Health Research University of Southern Denmark Odense Denmark

Medical Department Dronning Ingrids Hospital Nuuk Greenland

Medical Department Hospital of Southern Jutland Aabenraa Denmark

Medical Department The National Hospital of the Faroe Islands Torshavn Faroe Islands

Medical Department Viborg Regional Hospital Viborg Denmark

Nicosia Private Practice Nicosia Cyprus

On behalf of the EpiCom Northern Italy centre based in Crema and Cremona Firenze Forlì Padova and Reggio Emilia Italy

School of Health and Medical Sciences Örebro University Örebro Sweden

St Mark's Hospital Imperial College London London UK

U O Gastroenterologia ed Endoscopia Digestiva Ospedale Morgagni Pierantoni Forlì Italy

U O Medicina 3° e Gastroenterologia Azienda Ospedaliera Arcispedale S Maria Nuova Reggio Emilia Italy

000      
00000naa a2200000 a 4500
001      
bmc15023567
003      
CZ-PrNML
005      
20161026134806.0
007      
ta
008      
150709s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.crohns.2014.01.028 $2 doi
035    __
$a (PubMed)24560877
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Burisch, J $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark. Electronic address: burisch@dadlnet.dk.
245    10
$a Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study / $c J. Burisch, P. Weimers, N. Pedersen, S. Cukovic-Cavka, B. Vucelic, I. Kaimakliotis, D. Duricova, M. Bortlik, O. Shonová, I. Vind, S. Avnstrøm, N. Thorsgaard, S. Krabbe, V. Andersen, JF. Dahlerup, J. Kjeldsen, R. Salupere, J. Olsen, KR. Nielsen, P. Manninen, P. Collin, KH. Katsanos, EV. Tsianos, K. Ladefoged, L. Lakatos, G. Ragnarsson, E. Björnsson, Y. Bailey, C. O'Morain, D. Schwartz, S. Odes, D. Valpiani, MC. Boni, L. Jonaitis, L. Kupcinskas, S. Turcan, L. Barros, F. Magro, D. Lazar, A. Goldis, I. Nikulina, E. Belousova, A. Fernandez, L. Sanroman, S. Almer, Y. Zhulina, J. Halfvarson, N. Arebi, T. Diggory, S. Sebastian, PL. Lakatos, E. Langholz, P. Munkholm, . ,
520    9_
$a BACKGROUND & AIMS: Health-related quality of life (HRQoL) is impaired in patients with Inflammatory Bowel Disease (IBD). The aim was prospectively to assess and validate the pattern of HRQoL in an unselected, population-based inception cohort of IBD patients from Eastern and Western Europe. METHODS: The EpiCom inception cohort consists of 1560 IBD patients from 31 European centres covering a background population of approximately 10.1 million. Patients answered the disease specific Short Inflammatory Bowel Disease Questionnaire (SIBDQ) and generic Short Form 12 (SF-12) questionnaire at diagnosis and after one year of follow-up. RESULTS: In total, 1079 patients were included in this study. Crohn's disease (CD) patients mean SIBDQ scores improved from 45.3 to 55.3 in Eastern Europe and from 44.9 to 53.6 in Western Europe. SIBDQ scores for ulcerative colitis (UC) patients improved from 44.9 to 57.4 and from 48.8 to 55.7, respectively. UC patients needing surgery or biologicals had lower SIBDQ scores before and after compared to the rest, while biological therapy improved SIBDQ scores in CD. CD and UC patients in both regions improved all SF-12 scores. Only Eastern European UC patients achieved SF-12 summary scores equal to or above the normal population. CONCLUSION: Medical and surgical treatment improved HRQoL during the first year of disease. The majority of IBD patients in both Eastern and Western Europe reported a positive perception of disease-specific but not generic HRQoL. Biological therapy improved HRQoL in CD patients, while UC patients in need of surgery or biological therapy experienced lower perceptions of HRQoL than the rest.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a chirurgie trávicího traktu $x metody $7 D013505
650    12
$a management nemoci $7 D019468
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a idiopatické střevní záněty $x epidemiologie $x psychologie $x terapie $7 D015212
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a morbidita $x trendy $7 D009017
650    12
$a surveillance populace $7 D011159
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    12
$a kvalita života $7 D011788
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Weimers, P $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark.
700    1_
$a Pedersen, N $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark.
700    1_
$a Cukovic-Cavka, S $u Division of Gastroenterology and Hepatology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
700    1_
$a Vucelic, B $u Division of Gastroenterology and Hepatology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
700    1_
$a Kaimakliotis, I $u Nicosia Private Practice, Nicosia, Cyprus.
700    1_
$a Duricova, D $u IBD Center ISCARE, Charles University, Prague, Czech Republic.
700    1_
$a Bortlik, M $u IBD Center ISCARE, Charles University, Prague, Czech Republic.
700    1_
$a Shonová, O $u Gastroenterology Department, Hospital České Budějovice, České Budějovice, Czech Republic.
700    1_
$a Vind, Ida $u Department of Medicine, Amager Hospital, Amager, Denmark. $7 xx0207519
700    1_
$a Avnstrøm, S $u Department of Medicine, Amager Hospital, Amager, Denmark. $7 gn_A_00010376
700    1_
$a Thorsgaard, N $u Department of Medicine, Herning Central Hospital, Herning, Denmark.
700    1_
$a Krabbe, S $u Medical Department, Viborg Regional Hospital, Viborg, Denmark.
700    1_
$a Andersen, V $u Medical Department, Viborg Regional Hospital, Viborg, Denmark; Medical Department, Hospital of Southern Jutland, Aabenraa, Denmark; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark. $7 gn_A_00006096
700    1_
$a Dahlerup, J F $u Department of Medicine V, Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Kjeldsen, J $u Department of Medical Gastroenterology, Odense University Hospital, Odense, Denmark.
700    1_
$a Salupere, R $u Division of Endocrinology and Gastroenterology, Tartu University Hospital, Tartu, Estonia.
700    1_
$a Olsen, J $u Medical Department, The National Hospital of the Faroe Islands, Torshavn, Faroe Islands.
700    1_
$a Nielsen, K R $u Medical Department, The National Hospital of the Faroe Islands, Torshavn, Faroe Islands.
700    1_
$a Manninen, P $u Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
700    1_
$a Collin, P $u Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
700    1_
$a Katsanos, K H $u 1st Division of Internal Medicine and Division of Gastroenterology, Medical School, University of Ioannina, Ioannina, Greece.
700    1_
$a Tsianos, E V $u 1st Division of Internal Medicine and Division of Gastroenterology, Medical School, University of Ioannina, Ioannina, Greece.
700    1_
$a Ladefoged, K $u Medical Department, Dronning Ingrids Hospital, Nuuk, Greenland.
700    1_
$a Lakatos, L $u Department of Medicine, Csolnoky F. Province Hospital, Veszprem, Hungary.
700    1_
$a Ragnarsson, G $u Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland.
700    1_
$a Björnsson, E $u Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland.
700    1_
$a Bailey, Y $u Department of Gastroenterology, Adelaide and Meath Hospital, TCD, Dublin, Ireland.
700    1_
$a O'Morain, C $u Department of Gastroenterology, Adelaide and Meath Hospital, TCD, Dublin, Ireland.
700    1_
$a Schwartz, D $u Department of Gastroenterology and Hepatology, Soroka Medical Center and Ben Gurion University of the Negev, Beer Sheva, Israel; Department of Gastroenterology and Hepatology, Ben Gurion University of the Negev, Beer Sheva, Israel.
700    1_
$a Odes, S $u Department of Gastroenterology and Hepatology, Soroka Medical Center and Ben Gurion University of the Negev, Beer Sheva, Israel; Department of Gastroenterology and Hepatology, Ben Gurion University of the Negev, Beer Sheva, Israel.
700    1_
$a Valpiani, D $u U.O. Gastroenterologia ed Endoscopia Digestiva, Ospedale Morgagni - Pierantoni, Forlì, Italy; On behalf of the EpiCom Northern Italy centre based in Crema & Cremona, Firenze, Forlì, Padova and Reggio Emilia, Italy.
700    1_
$a Boni, M C $u U.O. Medicina 3° e Gastroenterologia, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy; On behalf of the EpiCom Northern Italy centre based in Crema & Cremona, Firenze, Forlì, Padova and Reggio Emilia, Italy.
700    1_
$a Jonaitis, L $u Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
700    1_
$a Kupcinskas, L $u Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
700    1_
$a Turcan, S $u Department of Gastroenterology, State University of Medicine and Pharmacy of the Republic of Moldova, Chisinau, Republic of Moldova.
700    1_
$a Barros, L $u Hospital de Vale de Sousa, Porto, Portugal.
700    1_
$a Magro, F $u Department of Gastroenterology, Hospital São João, Porto, Portugal; Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal; IBMC - Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal.
700    1_
$a Lazar, D $u Clinic of Gastroenterology, University of Medicine 'Victor Babes', Timisoara, Romania.
700    1_
$a Goldis, A $u Clinic of Gastroenterology, University of Medicine 'Victor Babes', Timisoara, Romania.
700    1_
$a Nikulina, I $u Department of Gastroenterology, Moscow Regional Research Clinical Institute, Moscow, Russian Federation.
700    1_
$a Belousova, E $u Department of Gastroenterology, Moscow Regional Research Clinical Institute, Moscow, Russian Federation.
700    1_
$a Fernandez, A $u Gastroenterology Department, POVISA Hospital, Vigo, Spain.
700    1_
$a Sanroman, L $u Gastroenterology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
700    1_
$a Almer, S $u Division of Gastroenterology and Hepatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Gastroenterology/UHL, County Council of Östergötland, Linköping, Sweden. $7 gn_A_00004634
700    1_
$a Zhulina, Y $u Department of Medicine, Division of Gastroenterology, Örebro University Hospital, Örebro, Sweden.
700    1_
$a Halfvarson, J $u Department of Medicine, Division of Gastroenterology, Örebro University Hospital, Örebro, Sweden; School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
700    1_
$a Arebi, N $u St. Mark's Hospital, Imperial College London, London, UK. $7 gn_A_00008191
700    1_
$a Diggory, T $u Hull and East Yorkshire NHS Trust & Hull and York Medical School, Hull Royal Infirmary, Hull, UK; Hull and York Medical School, Hull Royal Infirmary, Hull, UK.
700    1_
$a Sebastian, S $u Hull and East Yorkshire NHS Trust & Hull and York Medical School, Hull Royal Infirmary, Hull, UK; Hull and York Medical School, Hull Royal Infirmary, Hull, UK.
700    1_
$a Lakatos, P L $u 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
700    1_
$a Langholz, E $u Department of Medical Gastroenterology, Gentofte Hospital, Copenhagen, Denmark.
700    1_
$a Munkholm, P $u Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark.
700    1_
$a ,
773    0_
$w MED00166945 $t Journal of Crohn's & colitis $x 1876-4479 $g Roč. 8, č. 9 (2014), s. 1030-42
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24560877 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20161026135221 $b ABA008
999    __
$a ok $b bmc $g 1083904 $s 906560
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 8 $c 9 $d 1030-42 $i 1876-4479 $m Journal of Crohn's and colitis $n J Crohns Colitis $x MED00166945
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...